| Melissa Mecka, | |
|
1945 Route 33, Neptune, NJ 07753-4859 | |
| (732) 202-8074 | |
| Not Available |
| Full Name | Melissa Mecka |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1945 Route 33, Neptune, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043487713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26NN11066900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Mecka, 3700 Route 33, Suite C, Neptune, NJ 07753-3206 Ph: (732) 202-8074 | Melissa Mecka, 1945 Route 33, Neptune, NJ 07753-4859 Ph: (732) 202-8074 |
News Archive
Ultra-long-acting insulin degludec, an investigational basal insulin being developed by Novo Nordisk, showed significant blood sugar reductions in patients with type 2 diabetes.
NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.
PRI's "The World" recently spoke with Matt Ellingson, director of Program Development at Samaritan's Purse, an international Christian relief organization, who was part of a mission to North Korea this month during which five U.S.-based, non-governmental organizations were allowed to send observers to the country to monitor delivery of aid to areas affected by severe floods this past summer. The group "came away concerned about widespread malnutrition and starvation in North Korea" and "is now calling for an urgent humanitarian intervention," "The World" reports.
UC Davis cancer researchers have discovered significant differences in radiation-therapy response among patients with oropharyngeal cancer depending on whether they carry the human papillomavirus (HPV), a common sexually transmitted virus. The findings, published online today in The Laryngoscope Journal, could lead to more individualized radiation treatment regimens, which for many patients with HPV could be shorter and potentially less toxic.
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.
› Verified 1 days ago
Ms. Deborah Lynn Caputo, APRN, BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 4, Neptune, NJ 07753 Phone: 732-974-0003 Fax: 732-974-0366 | |
Ms. Tracy Elizabeth Mcintyre, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 444 Neptune Blvd, Second Floor, Neptune, NJ 07753 Phone: 723-775-5300 Fax: 732-775-1737 | |
Jennifer Levine, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1200 Jumping Brook Rd, Bldg 5, Ste 201, Neptune, NJ 07753 Phone: 732-643-4363 Fax: 732-643-4376 | |
Larissa Lobato, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 Highway 35 N, Neptune, NJ 07753 Phone: 732-456-7777 Fax: 848-251-2189 | |
Mrs. Stacey J. Musto, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1900 Corlies Ave., State Route 33, Neptune, NJ 07753 Phone: 732-663-1123 Fax: 732-663-1179 | |
Amanda Danielle Moroz, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1945 Nj-33, Neptune, NJ 07752 Phone: 732-775-5500 |